GILEAD SCIENCES, INC. Accounts Receivable 2008-2026 | GILD
Beta
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is GILEAD SCIENCES, INC.'s current accounts receivable?
GILEAD SCIENCES, INC. (GILD) annual accounts receivable for 2025 was $4.91B, a 11.15% increase from 2024. GILEAD SCIENCES, INC. accounts receivable for the quarter ending March 31, 2026 was $4.74B.
What was GILEAD SCIENCES, INC.'s accounts receivable in 2024?
GILEAD SCIENCES, INC. annual accounts receivable for 2024 was $4.42B, a 5.15% decline from 2023.
What was GILEAD SCIENCES, INC.'s accounts receivable in 2023?
GILEAD SCIENCES, INC. annual accounts receivable for 2023 was $4.66B, a 2.45% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year accounts receivable CAGR?
GILEAD SCIENCES, INC. accounts receivable grew at a compound annual growth rate (CAGR) of 0.09% from FY2020 to FY2025, going from $4.89B to $4.91B over 5 years.
Accounts Receivable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.1%
FY2020
$4.89B
→
FY2025
$4.91B
080910111213141516171819202122232425
5 years selected
Accounts Receivable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.91B | +11.2% | 10-K |
| FY2024 | $4.42B | -5.2% | 10-K |
| FY2023 | $4.66B | -2.4% | 10-K |
| FY2022 | $4.78B | +6.3% | 10-K |
| FY2021 | $4.49B | -8.2% | 10-K |
| FY2020 | $4.89B | +36.6% | 10-K |
| FY2019 | $3.58B | +7.7% | 10-K |
| FY2018 | $3.33B | -13.6% | 10-K |
| FY2017 | $3.85B | -14.7% | 10-K |
| FY2016 | $4.51B | -22.9% | 10-K |
| FY2015 | $5.85B | +26.3% | 10-K |
| FY2014 | $4.63B | +112.4% | 10-K |
| FY2013 | $2.18B | +24.6% | 10-K |
| FY2012 | $1.75B | -10.2% | 10-K |
| FY2011 | $1.95B | +20.3% | 10-K |
| FY2010 | $1.62B | +16.7% | 10-K |
| FY2009 | $1.39B | +35.8% | 10-K |
| FY2008 | $1.02B | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →